SCHEMBL29809868

SCHEMBL29809868

C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCNCC4)cc3)nc3c2COC3)c1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CTSC P53634 3/20 0.65
▸ BTK Q06187 9/20 0.60
▸ JAK3 P52333 8/20 0.60
▸ EGFR P00533 10/20 0.59
▸ KCNH2 Q12809 2/20 0.59
▸ JAK2 O60674 2/20 0.59
▸ JAK1 P23458 1/20 0.59
▸ CD69 Q07108 1/20 0.58
▸ BLK P51451 2/20 0.58
▸ ITK Q08881 2/20 0.58
▸ ABCB11 O95342 1/20 0.58
▸ ESR1 P03372 1/20 0.58
▸ CHRM2 P08172 1/20 0.58
▸ HTR1A P08908 1/20 0.58
▸ ADRA2A P08913 1/20 0.58
▸ ADORA3 P0DMS8 1/20 0.58
▸ CHRM1 P11229 1/20 0.58
▸ DRD1 P21728 1/20 0.58
▸ TBXA2R P21731 1/20 0.58
▸ SLC6A2 P23975 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29809985 0.93 BTK (0.69) BTKJAK3EGFRKCNH2JAK2
SCHEMBL24623409 0.91 BTK (0.71) CTSCBTKJAK3EGFRKCNH2
SCHEMBL29809929 0.91 BTK (0.71) CTSCBTKJAK3EGFRKCNH2
SCHEMBL29809896 0.89 BTK (0.63) CTSCBTKJAK3EGFRKCNH2
SCHEMBL29809873 0.89 EGFR (0.63) CTSCBTKJAK3EGFRKCNH2
SCHEMBL29809932 0.89 BTK (0.60) CTSCBTKJAK3EGFRKCNH2
SCHEMBL14914811 0.81 EGFR (0.85) CTSCBTKJAK3EGFRKCNH2
SCHEMBL29809872 0.81 CTSC (0.61) CTSCBTKJAK3EGFRKCNH2
SCHEMBL29809870 0.81 EGFR (0.73) CTSCBTKJAK3EGFRJAK2
SCHEMBL24623372 0.81 EGFR (0.62) BTKJAK3EGFRJAK2CD69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022149856-A1 COMPOUND FOR INHIBITING BRUTON'S TYROSINE KINASE, AND PHARMACEUTICAL USE THEREOF 주식회사 온코빅스 2022-07-14 — — WO claimed
WO-2022149856-A1 COMPOUND FOR INHIBITING BRUTON'S TYROSINE KINASE, AND PHARMACEUTICAL USE THEREOF 주식회사 온코빅스 2022-07-14 — — WO disclosed
Send feedback